| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 02/13/1997 | WO1997005241A2 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | WO1997005240A1 Regulated autocrine growth of mammalian cells |
| 02/13/1997 | WO1997005237A1 Sulphate-reducing bacterial strains and their use in the decontamination of water contaminated with sulphuric acid, metals and radioactive substances |
| 02/13/1997 | WO1997005236A1 Method for controlling culture of lactic bacteria |
| 02/13/1997 | WO1997005219A1 Vegetable oil enzymatic degumming process by means of aspergillus phospholipase |
| 02/13/1997 | WO1997005166A1 Transforming growth factor beta crystals |
| 02/13/1997 | WO1997005164A1 Papillomavirus polyprotein constructs |
| 02/13/1997 | WO1996035774A3 Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/13/1997 | DE19529696A1 Transgene Pflanzenzellen und Pflanzen mit gesteigerter Glykolyserate Transgenic plant cells and plants with increased glycolysis |
| 02/13/1997 | CA2228378A1 Cytidine deaminase cdna as a positive selectable marker for gene transfer, gene therapy and protein synthesis |
| 02/13/1997 | CA2228063A1 New sulfate-reducing bacteria strains and their use for decontaminating sulfuric-acid, metal-containing, radioactively contaminated water |
| 02/13/1997 | CA2227988A1 Mammalian pro-protein converting enzyme |
| 02/13/1997 | CA2227844A1 Herpes simplex virus diagnostics |
| 02/13/1997 | CA2227694A1 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | CA2227369A1 Inhibitors of farnesyl-protein transferase |
| 02/13/1997 | CA2225551A1 Helper viruses for preparing recombinant viral vectors |
| 02/13/1997 | CA2200606A1 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 02/12/1997 | EP0758020A2 The use of homologous amdS genes as selectable markers |
| 02/12/1997 | EP0757720A1 Trimerising polypeptides, their manufacture and use |
| 02/12/1997 | EP0757719A1 $g(a)-1-ANTICHYMOTRYPSIN ANALOGUES HAVING CHYMASE INHIBITING ACTIVITY |
| 02/12/1997 | EP0757696A1 Human sperm diagnostic |
| 02/12/1997 | EP0757557A1 Methods for inducing t cell tolerance to a tissue or organ graft |
| 02/12/1997 | EP0491023B1 Microbiological process for detecting toxic products by means of yeast strains |
| 02/12/1997 | EP0470184B1 Antibodies specific for cd4-binding domain of hiv |
| 02/12/1997 | CN1142856A Process for producing L-Lysine by fermentation |
| 02/12/1997 | CN1142855A Humanized antibodies and uses thereof |
| 02/12/1997 | CN1142854A C5a receptor antagonists having substantially no agonist activity |
| 02/12/1997 | CN1142852A The use of an alpha-amylase modified to improve oxidation stability in a combined desizing and bleaching process |
| 02/12/1997 | CN1142775A Preparation and use of immunoconjugates |
| 02/12/1997 | CN1142774A Vibrio cholerae 01(CVD111) and Non-01(CVD112 and CVD112RM) serogroup vaccine strains and methods of making same |
| 02/12/1997 | CN1142505A Anti-idiotypic antibodies which induce immune response against epidermal growth factor receptor |
| 02/12/1997 | CN1142502A Present invention relates to extraction of recombinant proteins produced by prokaryotic microorganism, especially by E. Coli |
| 02/11/1997 | US5602096 Contacting cell with glial growth factor |
| 02/11/1997 | US5602095 Recombinant pseudomonas exotoxin with increased activity |
| 02/11/1997 | US5602034 Genetic engineering |
| 02/11/1997 | US5602033 Coccidiosis vaccine |
| 02/11/1997 | US5602031 DNA encoding molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a liver stage antigen produced by p. falciparum in hepatocytes and compositions containing them |
| 02/11/1997 | US5602024 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
| 02/11/1997 | US5602021 Identifying wild-type protease capable of cleaving polypeptide homologous to target, introducing into host cells phage system containing phage encoding mutants and phage encoding gene product necessary for infection, culturing |
| 02/11/1997 | US5602019 Genetic engineering |
| 02/11/1997 | US5602018 Having uniform low glycosylation, improved thermal stability |
| 02/11/1997 | US5602014 Genetic engineering; hydrolyzing acrylonitrile with transformed microorganism of genus rhodococcus to produce acrylic acid |
| 02/11/1997 | US5602013 Process for producing N-substituted-1-deoxynojirimycin |
| 02/11/1997 | US5602012 Culturing a mutant strain of actinomadura roseorufa |
| 02/11/1997 | US5602010 DNA encoding equine-gamma interferon and recombinant production of equine IFN-γ polypeptides |
| 02/11/1997 | US5602007 Recombinant DNA molecules |
| 02/11/1997 | US5602004 Genetic engineering |
| 02/11/1997 | US5602003 N-acetylglucosaminyltransferase V gene |
| 02/11/1997 | US5601998 Culture medium and device for detection and enumeration of enterobacteriaceae |
| 02/11/1997 | US5601831 Vaccines for nontypable Haemophilus influenzae |
| 02/11/1997 | US5601827 Replacing or deleting certain codons of naturally-occuring diphtheria toxin |
| 02/11/1997 | US5601822 γ, δ T cell receptor and methods for detection |
| 02/11/1997 | US5601821 Histamine releasing peptide |
| 02/11/1997 | US5601799 Glycoprotein has affinity to macrophages, useage as drug delivery |
| 02/11/1997 | CA2055052C Low temperature inactive baker's yeast |
| 02/11/1997 | CA1338905C Fermentation and purification process for succinic acid |
| 02/11/1997 | CA1338902C Plant cells resistant to herbicidal glutamine synthetase inhibitors |
| 02/11/1997 | CA1338901C Recombinant dna sequences, vectors containing them and methods for the use thereof |
| 02/11/1997 | CA1338900C Escherichia coli plasmid vector with lipoprotein promoter and modified shine-dalgarno sequence |
| 02/06/1997 | WO1997004315A1 Protein p5, a serum marker for brain damage |
| 02/06/1997 | WO1997004120A1 Method for preparing pure lactic acid |
| 02/06/1997 | WO1997004109A1 α-β C4BP-TYPE RECOMBINANT HETEROMULTIMERIC PROTEINS |
| 02/06/1997 | WO1997004105A1 Dna polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis |
| 02/06/1997 | WO1997004102A1 Haloperoxidases from curvularia verruculosa and nucleic acids encoding same |
| 02/06/1997 | WO1997004099A2 Papillomaviruses, agents for detecting them and for treating diseases caused by such viruses |
| 02/06/1997 | WO1997004095A1 Novel protein hmw human mp52 |
| 02/06/1997 | WO1997004094A1 Nucleic sequences coding for melatonin receptors, and uses thereof |
| 02/06/1997 | WO1997004092A1 P53 protein variants and therapeutical uses thereof |
| 02/06/1997 | WO1997004089A2 Porphyrin-accumulating type herbicide resistance gene |
| 02/06/1997 | WO1997004088A1 Porphyrin-accumulating type herbicide resistance gene |
| 02/06/1997 | WO1997004084A1 Enzymes and microorganisms having amidase activity for hydrolysing polyamides |
| 02/06/1997 | WO1997004083A1 Enzymes and micro-organisms with amidase activity which hydrolyse polyamides |
| 02/06/1997 | WO1997004079A1 A modified enzyme with lipolytic activity |
| 02/06/1997 | WO1997004078A1 A modified enzyme with lipolytic activity |
| 02/06/1997 | WO1997004005A2 Cyclosporin derivatives with anti-hiv effect |
| 02/06/1997 | WO1997003944A1 Aliphatic tricarboxylic acid compounds and their production process |
| 02/06/1997 | WO1997003703A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| 02/06/1997 | WO1997003635A2 p16 EXPRESSION CONSTRUCTS AND THEIR APPLICATION IN CANCER THERAPY |
| 02/06/1997 | WO1997003574A1 Process for stabilizing proteins in an acidic environment with a high-ester pectin |
| 02/06/1997 | WO1996040766A3 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 02/06/1997 | WO1996037620A3 Process for obtaining acyloins, pyruvate decarboxylases suitable therefor and their production and dna sequences of the pdc gene coding them |
| 02/06/1997 | CA2227882A1 Protein p5, a serum marker for brain damage |
| 02/06/1997 | CA2227554A1 Nucleic sequences coding for melatonin receptors, and uses thereof |
| 02/06/1997 | CA2227277A1 Porphyrin-accumulating type herbicide resistance gene |
| 02/06/1997 | CA2227193A1 P16 expression constructs and their application in cancer therapy |
| 02/06/1997 | CA2227065A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| 02/06/1997 | CA2227030A1 .alpha.-.beta. c4bp-type recombinant heteromultimeric proteins |
| 02/06/1997 | CA2226872A1 Dna polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis |
| 02/06/1997 | CA2226625A1 Haloperoxidases from curvularia verruculosa and nucleic acids encoding same |
| 02/06/1997 | CA2225481A1 Process for stabilizing proteins in an acidic environment with a high-ester pectin |
| 02/06/1997 | CA2224289A1 New protein hmw human mp52s |
| 02/05/1997 | EP0757106A2 Nucleic acid-bondable magnetic carrier and method for isolating nucleic acid using the same |
| 02/05/1997 | EP0757101A2 Circular plasmids from Rhodococcus |
| 02/05/1997 | EP0757100A1 Over-expression and purification of a truncated thermostable DNA polymerase by protein fusion |
| 02/05/1997 | EP0757099A2 CTLA4 mutant molecules and uses thereof |
| 02/05/1997 | EP0757098A2 Heat resistant maltose phosphorylase, process for preparation thereof, bacteria used for preparation thereof, and methods for using the enzyme |
| 02/05/1997 | EP0757090A2 Process for the desulfurization and the desalting of fossil fuels |
| 02/05/1997 | EP0756639A1 Nucleic acids and methods for the discrimination between syncytium inducing and non syncytium inducing variants of the human immunodeficiency virus |
| 02/05/1997 | EP0756636A1 Chondroitinases i and ii, methods of preparation, and use thereof |
| 02/05/1997 | EP0756630A1 Recombinant pgp3, methods of preparation and use in diagnosis and therapy |